This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair.
Circulation · 2017
The third international meeting on genetic disorders in the RAS/MAPK pathway: towards a therapeutic approach.
American journal of medical genetics. Part A · 2015
Cell surface profiling using high-throughput flow cytometry: a platform for biomarker discovery and analysis of cellular heterogeneity.
PloS one · 2014
Latest funding
- $804,047
Cell of Origin and Tumor Initiating Cells in Serous Ovarian Cancer
CIHR · 2014 · Nominated PI
- $17,500
Cellular and Molecular Mechanisms Underlying Noonan Syndrome Cardiac Defects with RAF1 Mutations
CIHR · 2013 · Supervisor
- $1,400,000
CRC Tier 1
CIHR · 2013 · Nominated PI
3 publications.
Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair.
Tiburcy M, Hudson JE, Balfanz P, Schlick S, Meyer T, Chang Liao ML, Levent E, Raad F, Zeidler S, Wingender E, Riegler J, Wang M, Gold JD, Kehat I, Wettwer E, Ravens U, Dierickx P, van Laake LW, Goumans MJ, Khadjeh S, Toischer K, Hasenfuss G, Couture LA, Unger A, Linke WA, Araki T, Neel B, Keller G, Gepstein L, Wu JC, Zimmermann WH
The third international meeting on genetic disorders in the RAS/MAPK pathway: towards a therapeutic approach.
Korf B, Ahmadian R, Allanson J, Aoki Y, Bakker A, Wright EB, Denger B, Elgersma Y, Gelb BD, Gripp KW, Kerr B, Kontaridis M, Lazaro C, Linardic C, Lozano R, MacRae CA, Messiaen L, Mulero-Navarro S, Neel B, Plotkin S, Rauen KA, Roberts A, Silva AJ, Sittampalam SG, Zhang C, Schoyer L
Cell surface profiling using high-throughput flow cytometry: a platform for biomarker discovery and analysis of cellular heterogeneity.
Gedye CA, Hussain A, Paterson J, Smrke A, Saini H, Sirskyj D, Pereira K, Lobo N, Stewart J, Go C, Ho J, Medrano M, Hyatt E, Yuan J, Lauriault S, Meyer M, Kondratyev M, van den Beucken T, Jewett M, Dirks P, Guidos CJ, Danska J, Wang J, Wouters B, Neel B, Rottapel R, Ailles LE
Cell of Origin and Tumor Initiating Cells in Serous Ovarian Cancer
Principal investigators: Neel, Benjamin G
Keywords: Cancer Stem Cell; Cell Of Origin; Ovarian Cancer; Tumor Initiating Cells
Cellular and Molecular Mechanisms Underlying Noonan Syndrome Cardiac Defects with RAF1 Mutations
Principal investigators: Yin, Jiani
Keywords: Developmental Disorder; Transgenic Mice
CRC Tier 1
Principal investigators: Neel, Benjamin G
Keywords: Crc
The Gab/Par pathway in development and cancer
Principal investigators: Neel, Benjamin G
Keywords: Cancer; Cell Polarity; Signal Transduction
Cellular and Molecular Mechanisms of Cardiac Defects Associated with RASopathies
Principal investigators: Yin, Jiani
Keywords: Cardiovascular Disease; Developmental Disorder; Gene Expression Profiling; Pluripotent Stem Cell Differentiation; Transgenic Mice
The RAS-hVPS34-PTPRD pathway in lung tumorigenesis
Principal investigators: Neel, Benjamin G
Keywords: Autophagy; Hvps34; Lung Cancer; Ptprd; Ras
Systematic identification of resistance mechanisms to HER2-targeted therapies in breast cancer.
Principal investigators: Chang, Che-wei A
Keywords: Combination Therapy; Her2-Positive Breast Cancer; Her2-Targeted Therapy; Lapatinib; Lentiviral Shrna Screen; Therapeutic Resistance; Trastuzumab; Xenograph
Role of PTP1B in Her2+ breast cancer
Principal investigators: Neel, Benjamin G
Keywords: Breast Cancer; Her2; Ptp1b
The Molecular Basis of Noonan Syndrome-Associated RAF1 Mutations
Principal investigators: Wu, Xue
Keywords: Gene Knock-In Mouse Model; Germline Mutation; Hypertrophic Cardiomyopathy; Noonan Syndrome; Raf1; Ras-Raf-Mapk Pathway; Signal Transduction
Development of Redox Proteomics
Principal investigators: Karisch, Robert
Keywords: Cancer; Mass Spectrometry; Nadph Oxidase; Oxidation; Protein Tyrosine Kinases; Protein Tyrosine Phosphatases; Proteomics; Reactive Oxygen Species; Redox Signalling; Signal Transduction
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Medical Biophysics
- Department of Immunology
- Other
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.